Pfizer Hiring for Manufacturing and Junior / Assistant Associates
VisakhapatnamAny Diploma/ B.Sc
Job Details:
Junior / Assistant Associates
Manufacturing (Injectables)
Eligibility criteria:
Qualification: Any Diploma/ B.Sc (Full time)
Years of Experience: 1 to 6 Years should be from injectable manufacturing plant.
Job Description:
Operate production equipment such as Injectable, Sterile, Parenteral machines, Vial / Ampoule filling, Capping, Compounding, Washing, Sealing, Terminal sterilization, Stopper process & Visual inspection.
Monitor and control the production process to ensure quality products are produced within specified parameters.
Maintain accurate records of production data and perform routine maintenance tasks on equipment as required.
Collaborate with other team members to resolve issues and improve overall efficiency.
Ensure adherence to Good Manufacturing Practices (GMP) guidelines.
Must have experience with USFDA regulatory environment & process.
Interested and qualified applicants send your profile to pgsindiacxteam@pfizer.com and register using the provided QR code”.
About Pfizer
Pfizer Inc. is a leading global biopharmaceutical company headquartered in New York City. Founded in 1849 by Charles Pfizer and Charles F. Erhart, the company has grown into one of the world's largest pharmaceutical firms. Pfizer develops and manufactures medicines and vaccines across various therapeutic areas, including oncology, immunology, cardiology, endocrinology, and neurology.
Key Products and Revenue Streams
Comirnaty: The COVID-19 vaccine developed in partnership with BioNTech, generating $11 billion in revenue.
Paxlovid: An oral antiviral treatment for COVID-19, contributing $6.5 billion in sales.
Editable Business Templates
Eliquis: A blood thinner, with $6 billion in revenue.
Vyndaqel: A treatment for transthyretin amyloid cardiomyopathy, generating $4 billion.
Prevnar 13: A pneumococcal conjugate vaccine, with $6 billion in sales.
These products collectively accounted for a significant portion of Pfizer's revenue in 2023.
Editable Business Templates
Recent Acquisitions and Strategic Moves
Pfizer has expanded its portfolio through strategic acquisitions:
Seagen: In December 2023, Pfizer acquired Seagen, a leader in antibody-drug conjugates for cancer treatment, for $43 billion.
Biohaven Pharmaceuticals: In October 2022, Pfizer acquired Biohaven for $11.6 billion, enhancing its capabilities in treating neurological diseases.
Global Blood Therapeutics: Acquired for $5.4 billion, strengthening Pfizer's position in the rare disease space.
Operations in India
Pfizer has a significant presence in India, operating since 1950. The company operates through three entities:
Pfizer Limited: Listed on the Bombay Stock Exchange, it is the fourth-largest multinational pharmaceutical company in India, with annual sales exceeding ₹2,000 crores.
Pfizer Products India Pvt Ltd: A wholly owned subsidiary engaged in the import, trade, and distribution of pharmaceutical products.
Pfizer Healthcare India Pvt Ltd: Formerly Hospira Healthcare India Pvt Ltd, this entity focuses on manufacturing and research, including a state-of-the-art sterile injectables' manufacturing site in Visakhapatnam.
Financial Overview
For the fiscal year 2024, Pfizer reported:
Revenue: $63.6 billion
Pfizer
Net Income: $8.02 billion
Operating Income: $10.6 billion
Assets: $219.4 billion
The company maintains a strong financial position, with a market capitalization of approximately $125.56 billion as of April 2025.
Leadership
Albert Bourla serves as the Chairman and CEO of Pfizer. Under his leadership, the company has navigated challenges such as the COVID-19 pandemic and subsequent vaccine distribution. However, Bourla has faced scrutiny from activist investors regarding post-pandemic strategies and stock performance.
